期刊文献+

奥美拉唑不良反应文献分析 被引量:4

Literature Analysis of Omeprazole-induced Adverse Drug Reactions
下载PDF
导出
摘要 目的:探讨奥美拉唑不良反应发生的规律及特点,为临床合理用药提供参考。方法:通过中国知网(CNKI)的中国医院知识仓库(CHKD)期刊全文数据库及万方数据库检索到2000~2010年有关奥美拉唑致不良反应的有效文献,并按患者性别、年龄、原患疾病与过敏史、给药途径、累及器官或系统及临床表现等方面进行统计、分析。结果:收集奥美拉唑所致不良反应50例,其中,不良反应以过敏性反应和血液系统反应最多。结论:奥美拉唑引起的不良反应临床表现复杂多样,其发生与多种因素有关,值得临床医师关注。 Objective:To explore the regularity and characteristics of ADRs induced by omeprazole. Method: Based on the CHKD and Wanfang database,literatures about omeprazoleinduced ADRs from 2000 to 2010 were collected and statistically afialyzed in respect of patients' gender, age, case history, administration route, clinical manifestation. Result :The most ADRs were anaphylactic reactions and hematological system damage. Conelnsion: ADRs induced by omeprazole presented complicated and various symptoms owing to different reasons. Clinical doctors should pay more attention to the omeprazole-induced ADRs.
作者 陈颖 封宇飞
出处 《药物流行病学杂志》 CAS 2011年第10期544-547,共4页 Chinese Journal of Pharmacoepidemiology
基金 卫生行业科研专项基金(编号:200902008-03)
关键词 奥美拉唑 药品不良反应 文献分析 Omeprazole Adverse drug reactions Literature analysis
  • 相关文献

参考文献13

二级参考文献32

  • 1骆泽宇.奥美拉唑的临床合理应用及不良反应[J].现代中西医结合杂志,2005,14(24):3314-3315. 被引量:12
  • 2Anderson JL,Adams CD,Antman EM,et al.ACC/AHA2007 guidelines for the management of paints with unstable angina/non-ST-elevation myocardial infarction.J Am Coll Cardiol,2007,50(7):e1-e157
  • 3Bhatt DL,Scheiman J,Abraham NS,et al.ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use:a report of the American Documents.Circulation,2008,118(18):1894-1909
  • 4Gilard M,Arnaud B,Le Gal G,et al.Influence of omeprazol on the anpiplatelet action of clopidogroi associated to aspirin.J Thromb Hacmost,2006,4(11):2508-2509
  • 5Gilard M,Arnand B,Cornily JC,et al.Influence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin:the randomized,doublehlind OCLA(Omeprazole CLopidogrel Aspirin)study.J Am Coll Cardiol,2008,51(3):256-260
  • 6Food and Drug Administration.Early Communication about an ongoing safety review of clopidogrel bisulfate(marketed as Plavix).http://www.fda.gov/cder/drug/early comm/clopidogrel bisulfate.htm.Accessed January 26,2009
  • 7Ho P.M,Maddox MT,Wang L et al.Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndromes.JAMA,2009,301(9):937-944
  • 8Aubert RE,Epstein RS,Teasarden JR,et al.Abstract 3998:Proton pump inhihitors effect on clopidogrel effectiveness:the Clopidogrel Medco Outcomes Study.Circulation,2008,118(suppl.):S815
  • 9Juurlink DN,Gomes T,Ko DT,et al.A population-based study of the drug interaction between proton pump inhibitors and clopidogrel.CMAJ,2009,180(7):699-700
  • 10Geiger J,Brich J,Honig-Liedl P,et al.Specific impairment of human platelet P2Y(AC)ADP receptor2 mediated signaling by the antiplatelet drug clopidogrel.A rterioscler Thromb Vasc Biol,1999,19(8):2007-2011

共引文献63

同被引文献28

引证文献4

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部